Eterna Therapeutics Acquires Allogeneic Immuno-Oncology Platform from Exacis Biotherapeutics

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/26/2026

1. NVDA
2. DKS
3. SPY
4. INTU
5. AAPL
6. ZM
7. SPCX
8. USO
9. XPEV
10. BMO

Go back to Eterna Therapeutics Acquires Allogeneic Immuno-Oncology Platform from Exacis Biotherapeutics
(NASDAQ: ERNA) Delayed: 4.93 --0 (-0%)
Previous Close $4.93    52 Week High $ 
Open $4.93    52 Week Low $ 
Day High $4.93    P/E N/A 
Day Low $4.93    EPS $ 
Volume 537